Carlsmed Current Ratio 2025-2025 | CARL
Carlsmed current ratio from 2025 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Carlsmed Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-09-30 | $0.13B | $0.01B | 12.03 |
| 2025-06-30 | $0.00B | 0.00 | |
| 2025-03-31 | $0.00B | 0.00 | |
| 2024-12-31 | $0.05B | $0.01B | 5.60 |
| 2024-09-30 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.360B | $0.027B |
| Carlsmed Inc. is a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions. Carlsmed Inc. is based in CARLSBAD, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $35.991B | 41.62 |
| Tempus AI (TEM) | United States | $12.261B | 0.00 |
| Doximity (DOCS) | United States | $7.729B | 31.82 |
| Hims & Hers Health (HIMS) | United States | $7.109B | 57.83 |
| IRHYTHM HLDGS (IRTC) | United States | $5.543B | 0.00 |
| Hinge Health (HNGE) | United States | $3.445B | 0.00 |
| Heartflow (HTFL) | United States | $3.076B | 0.00 |
| Privia Health (PRVA) | United States | $2.935B | 183.54 |
| Inspire Medical Systems (INSP) | United States | $2.803B | 46.38 |
| 10x Genomics (TXG) | United States | $2.683B | 0.00 |
| Omnicell (OMCL) | United States | $2.288B | 46.77 |
| Azenta (AZTA) | United States | $1.835B | 75.30 |
| Enovis (ENOV) | United States | $1.387B | 7.29 |
| Clover Health Investments (CLOV) | United States | $1.354B | 0.00 |
| Schrodinger (SDGR) | United States | $1.287B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.149B | 0.00 |
| Phreesia (PHR) | United States | $0.992B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.886B | 0.00 |
| Talkspace (TALK) | United States | $0.634B | 127.67 |
| Standard BioTools (LAB) | United States | $0.608B | 0.00 |
| Claritev (CTEV) | United States | $0.497B | 0.00 |
| Evolent Health (EVH) | United States | $0.440B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.349B | 0.00 |
| TruBridge (TBRG) | United States | $0.326B | 14.99 |
| Zepp Health (ZEPP) | Netherlands | $0.326B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.297B | 0.00 |
| CapsoVision (CV) | United States | $0.283B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.263B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.190B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.175B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.175B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.166B | 0.00 |
| CareCloud (CCLD) | United States | $0.121B | 6.63 |
| Outset Medical (OM) | United States | $0.095B | 0.00 |
| American Well (AMWL) | United States | $0.078B | 0.00 |
| HeartBeam (BEAT) | United States | $0.076B | 0.00 |
| Pulmonx (LUNG) | United States | $0.075B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.069B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.067B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.061B | 0.00 |
| 111 (YI) | China | $0.049B | 0.00 |
| Precipio (PRPO) | United States | $0.042B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.040B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.024B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.022B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Zhongchao (ZCMD) | China | $0.012B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.009B | 0.00 |
| PROFUSA (PFSA) | United States | $0.009B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |